INDIANAPOLIS and TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life changing ...
POINT Biopharma Global Inc (NASDAQ: PNT) and Isotopia Molecular Imaging Limited have signed a clinical supply agreement for the medical radioisotope no-carrier-added Lutetium-177 (Lu-177), a ...